“We find that people who are in better shape fill fewer prescriptions for anxiety and depression medications,” says Linda Ernstsen, the senior author of the article and an… read more.
Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia… read more.
Sage Therapeutics, Inc .and Biogen Inc. announced the FDA approved Zurzuvae (zuranolone) 50 mg for adults with postpartum depression (PPD). Zurzuvae is the first and only oral, once-daily,… read more.
More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about… read more.
A new talking therapy for depression has shown encouraging early signs of being more effective and cheaper to deliver than the current best practice of Cognitive Behavioural Therapy… read more.
New research is tackling the mental health crisis in the construction industry – highlighting the benefits of an on-site Health Hub on worker wellbeing. The construction industry has… read more.
Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today… read more.
A study involving more than 745,000 adolescents from 41 countries across Europe and North America identified an increase in the amount of teenagers who underestimate their body weight…. read more.
People caring for family members at home (family caregivers) face more substantial psychological and physical challenges than noncaregivers. Therefore, healthcare professionals must pay attention to the stress of… read more.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were… read more.
Researchers from The University of Texas at El Paso’s School of Pharmacy will explore the viability of a new treatment for vascular dementia, thanks to a $2.2 million… read more.
In a global perspective, depression is the leading cause of ill health and disability. More than 264 million people are affected and at least 25 per cent of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
